BiotechTube

rabeprazole sodium + placebo

Phase 3Completed
0 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Heartburn

Conditions

Heartburn

Trial Timeline

Oct 1, 2005 → Jun 1, 2008

NCT ID
NCT00236197

About rabeprazole sodium + placebo

rabeprazole sodium + placebo is a phase 3 stage product being developed by Eisai for Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT00236197. Target conditions include Heartburn.

What happened to similar drugs?

7 of 14 similar drugs in Heartburn were approved

Approved (7) Terminated (0) Active (7)
✅esomeprazole 40 mgAstraZenecaApproved
✅Esomeprazole magnesium (Nexium)AstraZenecaApproved
✅Esomeprazole + Lansoprazole + PantoprazoleAstraZenecaApproved
✅Esomeprazole Magnesium + LansoprazoleAstraZenecaApproved
✅Esomeprazole 20 mg + PlaceboPfizerApproved
✅Talcid (Hydrotalcite, BAY4516H) + Famotidine + PlaceboBayerApproved
✅Omeprazole 20 mg + Sodium Bicarbonate 1100 mg + Omeprazole 20 mgBayerApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT00911534Phase 3Completed
NCT00236197Phase 3Completed

Competing Products

20 competing products in Heartburn

See all competitors
ProductCompanyStageHype Score
rabeprazole sodiumEisaiPhase 3
40
Rabeprazole sodiumEisaiPre-clinical
26
famotidine (+) calcium carbonate (+) magnesium hydroxide tablet + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet without water + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet with waterJohnson & JohnsonPhase 1
29
esomeprazole 40 mgAstraZenecaApproved
43
Esomeprazole magnesium (Nexium)AstraZenecaApproved
43
EsomeprazoleAstraZenecaPhase 3
40
EsomeprazoleAstraZenecaPhase 3
40
Esomeprazole + Lansoprazole + PantoprazoleAstraZenecaApproved
43
Esomeprazole Magnesium + LansoprazoleAstraZenecaApproved
43
Famotidine FCT + Famotidine CTMerckPhase 1
29
LanzoprazoleNovartisPhase 3
40
Lansoprazole + Lansoprazole + placeboNovartisPhase 3
40
LansoprazoleNovartisPhase 3
40
TegaserodNovartisPhase 3
40
Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mg + Lansoprazole + Calcium carbonate/magnesium hydroxide + PlaceboNovartisPhase 2
35
Esomeprazole 20 mg + PlaceboPfizerApproved
43
bi-layer calcium carbonate tablet (BAY1180654) + Immediate release calcium carbonate tablet (BAY1180654)BayerPhase 1
26
omeprazole/sodium bicarbonate + omeprazole magnesiumBayerPhase 1
26
Talcid (Hydrotalcite, BAY4516H) + Famotidine + PlaceboBayerApproved
40
Omeprazole 20 mg + Sodium Bicarbonate 1100 mg + Omeprazole 20 mgBayerApproved
40